Insulin Makers Ask 2nd Circ. To Rethink Collusion Claims

By Matthew Perlman · September 11, 2025, 8:14 PM EDT

Sanofi-Aventis US, Eli Lilly & Co., Novo Nordisk Inc. and AstraZeneca Pharmaceuticals LP are asking for a rehearing after a Second Circuit panel revived a proposed class action from safety-net hospitals and...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login